Abstracts

332 – Unique SARS-CoV-2 Variants and Inflammatory Milieu in Urine of Severe COVID-19 Participants

Background Acute kidney injury (AKI) is a common complication in people hospitalized with COVID-19. The etiology of AKI is likely multifactorial, with potential contributions from hemodynamic compromise, systemic inflammation, cytokine release, and local viral infection. People with COVID-19 and AKI have higher levels of systemic markers of inflammation than those with normal kidney function. To…

439 – Antibody Responses Decline Post-MVA Vaccination but Persist Following Mpox Infection

Background Clade IIb mpox cases have declined globally, likely due to vaccine and post-infection immunity alongside behavioural changes. However, breakthrough infections in vaccinated individuals and reports of reinfections raise questions about immune durability and the need for vaccine booster doses. We aimed to assess the durability of antibody responses following mpox and Modified Vaccinia Ankara (MVA)…

415 – Antigen Affinity Ceiling for Selection of Functional Mutations and HIV-1 Neutralization

Background The mechanism by which B cells sense antigen affinity and initiate signaling that leads to full B activation and differentiation remains unclear. Understanding the relationship between antigen affinity/kinetic rates and selection of functional mutations is critical for HIV-1 Envelope (Env) protein immunogens designed to target broadly neutralizing antibody (bnAb) precursors. Previously, we had reported…

530 – AZD5582 Inhibits Vaccine-Elicited CD8+ T-Cell Responses in SIV-Infected Rhesus Macaques on ART

Background At CROI 2024 (abstract 180), we reported that mRNA/SIV-Gag vaccination during ART and with boost prior to ART interruption (ATI) delayed time to rebound and induced early virologic control in SIV-infected rhesus macaques (RM). In this study, we explored whether the latency-reversing agent AZD5582 can be used to enhance efficacy of the mRNA/SIV-Gag vaccine.…

1293 – Dynamic Choice HIV Prevention With Cabotegravir (CAB-LA): A Model-Based Cost-Effectiveness Analysis

Background The SEARCH dynamic choice HIV prevention (DCP) intervention, including structured choice of biomedical prevention modality (oral PrEP, PEP, Cab-LA) with option to switch over time, increased time covered by biomedical prevention and reduced HIV incidence among men and women in randomized trials in Kenya and Uganda. We use HIV Synthesis, an existing individual-based HIV…

1352 – “I Like It but I Can’t Be the First”: Sex Workers’ Preferences for LAI PrEP Delivery in South Africa

Background Long-acting injectable PrEP (LAI-PrEP) represents an efficacious HIV prevention strategy, but rollout in 2024 has been limited, constraining our understanding of LAI-PrEP implementation within real-world HIV programs. We explored preferences and potential barriers to uptake and continuation of LAI-PrEP among female sex workers (FSW) accessing routine community-based HIV prevention services in South Africa. Methods…

1341 – A Comparative Analysis of Access and Retention of Oral PrEP and CAB-LA at 1 Month in Zambia

Background Pre-exposure prophylaxis (PrEP) is pivotal in HIV prevention. The recent introduction of long-acting injectable PrEP, alongside oral PrEP.  The USAID DISCOVER-Health project, implemented by JSI, has layered injectable PrEP onto its existing oral PrEP service delivery platform. This study examines how layering injectable PrEP onto existing oral PrEP services affects initiation and retention at…

1325 – Impact of Differentiated HIV Service Delivery Models on Quality of Life in Uganda

Background Differentiated service delivery (DSD) models have reduced strain on health services and improved client experience, retention and viral suppression, but little is known about the impact of HIV DSD models on quality of life (QoL), which is essential for optimizing person-centered care. This study assessed the impact of DSD models on QoL, loss to follow-up (LTFU), and mortality among persons living with…

1301 – Impact of SEARCH Person-Centered Care/Prevention on Clinical Outcomes by Alcohol Use in East Africa

Background Person-centered HIV care and prevention that provide low-barrier access and non-judgmental interactions may address poor outcomes among persons with alcohol use. Alcohol use is a risk factor for: a) non-retention in care and viremia among PWH, and b) non-retention in biomedical prevention and HIV acquisition among persons without HIV. We sought to determine if…

1314 – Hair Salons as a Promising Space to Offer HIV Prevention Services for Young Women in Lesotho

Background Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual reproductive health (SRH) challenges. There is a need for more accessible and de-medicalized community spaces to offer person-centred HIV/SRH services for this key population. We aimed to assess the acceptability and feasibility of offering HIV/SRH services at hair salons…